3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
5
Completed
4
Unknown
2
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
CNS
1
Conditions
Myelodysplastic Syndromes
243
Leukemia, Myeloid, Acute
191
Leukemia
145
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Precursor Cell Lymphoblastic Leukemia-Lymphoma
120
Myeloproliferative Disorders
89
Multiple Myeloma
84
Leukemia, Lymphocytic, Chronic, B-Cell
78
Lymphoma, Non-Hodgkin
76
Primary Myelofibrosis
72
Leukemia, Myelomonocytic, Chronic
68
Lymphoma
67
Hodgkin Disease
66
Leukemia, Myeloid, Chronic-Phase
55
Lymphoma, Mantle-Cell
50
Blast Crisis
49
Lymphoma, Large B-Cell, Diffuse
47
Lymphoma, Follicular
44
Leukemia, Myeloid, Accelerated Phase
44
Congenital Abnormalities
41
Lymphoma, B-Cell, Marginal Zone
40
Burkitt Lymphoma
40
Neoplasms, Plasma Cell
38
Lymphoma, Large-Cell, Immunoblastic
35
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
35
Polycythemia Vera
32
Hematologic Neoplasms
31
Myelodysplastic-Myeloproliferative Diseases
30
Lymphoma, T-Cell, Cutaneous
29
Anemia, Refractory, with Excess of Blasts
29
Interventions
Phlebotomy
1
Hydroxyurea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Thrombosis
×
Myeloid
×
Clear all
NCT01645124
2012-07-20
CYTO-PV
Consorzio Mario Negri Sud
Phase 3
Terminated
365 enrolled